BeStock  

BioLife Solutions BLFS

US equityMarket cap rank #2708Medical Instruments & Supplies
$0.00 +$0.00 (0.00%)
Market closed · Oct 22, 12:40 am ET
Open$0.00
Prev close$0.00
Day range$0.00 – $0.00
Volume0.00
Market cap$1.89B
P/E (TTM)32.7
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership101.9%-0.22 pts vs. prior quarter
Institutions holding264+7 vs. prior quarter
Insider trades (recent)5 buys / 45 sellsNet selling
Short interest8.17% of floatDays to cover 4.3 · as of 30 Sep 2026
Short-sale volume share17.8%5-day average of daily volume

Short-sale volume as % of daily volume

10%15%19%23%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$5.60M (6 inflow days, 14 outflow days).

Net flow by order size, last 20 sessions

−$18.6MSuper+$13.0MBig+$984.8KMid+$6.5MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 40.1% of shares outstanding.

Largest holders

  • BlackRock13.04%
  • Casdin Capital, LLC9.52%
  • T. Rowe Price Group, Inc.7.50%
  • Glazer Capital, LLC5.49%
  • Vanguard Capital Management, LLC4.57%
  • Invesco Ltd.4.45%
  • State Street Global Advisors3.39%
  • Geode Capital Management, LLC2.22%

By investor type

  • Mutual Fund74.49%
  • Hedge Fund10.48%
  • VC/PE Fund9.52%
  • Public Company3.07%
  • Individual/Insider2.93%
  • Government Pension Fund1.53%
  • Insurance Company1.25%
  • Private Company1.15%

Reported short interest has risen from 5.85% to 8.17% of float over the last 6 biweekly reports (15 Jul 2026 to 30 Sep 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Glazer Capital, LLC Hedge Fund 2026/Q3 +2,685,520 5.5%
Axiom Investors LLC Mutual Fund 2026/Q3 +171,590 0.4%
Millennium Management LLC Hedge Fund 2026/Q3 +625,658 1.3%
UBS Asset Management Mutual Fund 2026/Q3 +574,158 1.9%
Roubaix Capital, LLC Hedge Fund 2026/Q3 +309,618 0.6%
BlackRock Mutual Fund 2026/Q3 +273,780 13.0%
Goldman Sachs Asset Management, L.P. Mutual Fund 2026/Q3 +235,314 0.8%
Thrivent Investment Management, Inc. Mutual Fund 2026/Q3 +213,744 0.5%
Next Century Growth Investors LLC Mutual Fund 2026/Q3 +196,889 1.1%
Jane Street Group, LLC Private Company 2026/Q3 +183,061 0.4%
Diamond Hill Capital Management, LLC Mutual Fund 2026/Q3 +153,887 0.3%
Squarepoint OPS LLC Hedge Fund 2026/Q3 +132,942 0.3%
Susquehanna International Group, LLP Private Company 2026/Q3 +127,996 0.3%
Geode Capital Management, LLC Mutual Fund 2026/Q3 +114,938 2.2%
State Street Global Advisors Mutual Fund 2026/Q3 +78,851 3.4%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
17 Sep 2026 Roderick de Greef Director Sale to Issuer -2,775 $36.69 415,552
17 Sep 2026 Aby Mathew Chairman of Scientific Advisory Board, Executive VP & Chief Scientific Officer Sale to Issuer -564 $36.69 387,269
17 Sep 2026 Todd Berard Chief Marketing Officer Sale to Issuer -470 $36.69 161,823
17 Sep 2026 Troy Wichterman Chief Financial Officer Sale to Issuer -937 $36.69 211,286
17 Sep 2026 Sean Werner Chief Technology Officer Sale to Issuer -421 $36.69 47,135
7 Sep 2026 Aby Mathew Chairman of Scientific Advisory Board, Executive VP & Chief Scientific Officer Sale to Issuer -627 $35.38 387,833
7 Sep 2026 Todd Berard Chief Marketing Officer Sale to Issuer -356 $35.38 162,293
7 Sep 2026 Troy Wichterman Chief Financial Officer Sale to Issuer -1,026 $35.38 212,223
16 Jul 2026 Sean Werner Chief Technology Officer Sale to Issuer -275 $29.15 47,556
6 Jul 2026 Aby Mathew Chairman of Scientific Advisory Board, Executive VP & Chief Scientific Officer Sale to Issuer -516 $27.79 388,460
6 Jul 2026 Todd Berard Chief Marketing Officer Sale to Issuer -293 $27.79 162,649
6 Jul 2026 Troy Wichterman Chief Financial Officer Sale to Issuer -844 $27.79 213,249
17 Jun 2026 Roderick de Greef Director Sale to Issuer -2,775 $26.04 386,596
17 Jun 2026 Aby Mathew Chairman of Scientific Advisory Board, Executive VP & Chief Scientific Officer Sale to Issuer -564 $26.04 388,976
17 Jun 2026 Todd Berard Chief Marketing Officer Sale to Issuer -470 $26.04 162,942
17 Jun 2026 Troy Wichterman Chief Financial Officer Sale to Issuer -937 $26.04 214,093
17 Jun 2026 Sean Werner Chief Technology Officer Sale to Issuer -420 $26.04 47,831
7 Jun 2026 Aby Mathew Chairman of Scientific Advisory Board, Executive VP & Chief Scientific Officer Sale to Issuer -627 $26.10 389,540
7 Jun 2026 Todd Berard Chief Marketing Officer Sale to Issuer -356 $26.10 163,412
7 Jun 2026 Troy Wichterman Chief Financial Officer Sale to Issuer -1,026 $26.10 215,030

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Sep 2026 3,999,252 8.2% 4.3
15 Sep 2026 3,884,193 7.9% 4.5
31 Aug 2026 3,925,949 8.0% 4.8
14 Aug 2026 4,017,528 8.2% 7.8
31 Jul 2026 4,544,348 9.3% 2.1
15 Jul 2026 2,856,425 5.8% 5.0

Discussion

No comments yet — be the first to weigh in on BLFS.

Sign in to join the discussion.

Scroll to Top